Estimation application downloads and cost
Description
Buy IBM Micromedex® NeoFax today for only $29.99 USD per year. You will be prompted to purchase the app after your initial download. If your institution already subscribes to IBM Micromedex® NeoFax® then this app is FREE.
IBM Micromedex NeoFax is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
IBM Micromedex® is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Micromedex for more than 30 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
IBM Micromedex NeoFax drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
Do you work at a facility that subscribes to IBM Micromedex® NeoFax®? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to IBM Micromedex® NeoFax®, FREE access to these apps requires a password. To obtain the IBM Micromedex NeoFax password contact support at https://www-01.ibm.com/software/support/watsonhealth/truven_support.html.
Read more
IBM Micromedex NeoFax is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
IBM Micromedex® is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Micromedex for more than 30 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
IBM Micromedex NeoFax drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
Do you work at a facility that subscribes to IBM Micromedex® NeoFax®? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to IBM Micromedex® NeoFax®, FREE access to these apps requires a password. To obtain the IBM Micromedex NeoFax password contact support at https://www-01.ibm.com/software/support/watsonhealth/truven_support.html.
IBM Micromedex NeoFax screenshorts
ASO analyse IBM Micromedex NeoFax app for iPhone and iPad
| # | Term | Store county | Place | Priority |
|---|---|---|---|---|
| 1 | micromedex drug information | 5 |
Competitors of IBM Micromedex NeoFax application
| # | App | Common words |
|---|---|---|
| 1 | Micromedex Drug Reference | 9 |
| 2 | IBM Micromedex Drug Int. | 9 |
| 3 | IBM Micromedex Drug Info | 9 |
| 4 | IBM Micromedex Pediatrics | 9 |
| 5 | AHFS Clinical Drug Information | 9 |
Application availability
Available in countries
| Country | Price |
|---|---|
| Canada | free |
| USA | free |
Available for devices
iPhone3GS, iPhone4, iPodTouchFourthGen, iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE, iPhone7, iPhone7Plus, iPad611, iPad612, iPad71, iPad72, iPad73, iPad74, iPhone8, iPhone8Plus, iPhoneX,Other apps from Truven Health Analytics Inc.
Similar apps
